ANALYSIS OF COMPLIANCE WITH THE NEW STRATEGY FOR MANAGING SEPSIS PATIENTS AND INFECTION PREVENTION DURING INTENSIVE THERAPY. RESULTS OF MULTICENTER STUDY
https://doi.org/10.21292/2078-5658-2015-12-2-7-13
Abstract
This article analyzes compliance with basic current international and national recommendations for managing sepsis patients and infection prevention in the critical care departments of medical units located on the territory of Russia. The study was conducted by means of interactive polling during special training sessions devoted to sepsis ("Sepsis Schools") during 2013–2014 run in 45 large cities of Russia covering almost all regions of the country. The total number of responding doctors made 2,915 persons. The obtained data have proven that the main problems are inadequate provision with modern equipment and technologies for microbiological diagnostics and the absence of laboratory service available for 24 hours. There is significant lack of knowledge about role of biomarkers for sepsis diagnostics. Dopamine and hetastarch are unnecessary widely used to treat septic shock. More than half of specialists can not start empiric antimicrobal therapy with the optimal agent within the first hour after the diagnosis is clear.
About the Authors
V. V. Kulabukhov
A.V. Vishnevsky Institute of Surgery
Russian Federation
Russian Federation
V. A. Rudnov
Ural State Medical University
Poland
Poland
References
1. Bagin V.A., Rudnov V.A., Savitsky A.A. et al. Impact of colloid solutions on hospital mortality in sepsis associated acute renal disorder. Vestnik Anasteziol. i Reanimatol., 2014, no. 6, pp. 38¬44. (In Russ.)
2. Diagnostika i lecheniye mikoza v otdeleniyakh reanimatsii i intensivenoy terapii. Rossiyskiye natsionalnye rekomendatsii. [Diagnostics and treatment of fungal infection in critical care departments. Russian national guidelines]. Edited by N.N. Klimko. Moscow, Kompaniya BORGES Publ., 2011, 86 p.
3. Rudnov V.A., Dekhnich A.V., Belsky D.V. et al. Prevalence of infections in the intensive care department of Russia. Clin. Microbiol. Antimicrob. Khimioter. 2011, vol. 13, no. 4, pp. 294¬303. (In Russ.)
4. Sepsis v nachale XXI v. Klassifikatsiya, kliniko-diagnosticheskaya kontseptiya i lecheniye. Patologoanatomicheskaya diagnostika: prakticheskoye rukovodstvo. [Sepsis in early XXI cen. Classification, clinical and diagnostic concept and treatment. Postmortem diagnostics: manual]. Moscow, NTSSH im. A. N. Bakuleva RAMN Publ., 2004, 130 p.
5. Sepsis: klassifikatsiya, kliniko-diagnosticheskaya kontseptsiya i lecheniye: prakticheskoye rukovodstvo. [Sepsis: classification, clinical and diagnostic concept and treatment: manual]. Edited by V.S. Saveliev, B.R. Gelfand, 2nd rev., amend. and suppl. Moscow, OOO Meditsinskoye informatsionnoye agentstvo Publ., 2010, 392 p.
6. Asfar I., Senser A. Is procalcitonin a diagnostic and /or prognostic marker in sepsis? Infect. Dis. Clin. Pract. 2015, vol. 23, pp. 3¬6.
7. Behnes M., Bertsch T., Lepiorz D. et al. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit. Care. 2014, vol. 18, 507 p.
8. Chamberlain D., Willis E., Bernstein A. The severe sepsis bundles as processes of care: A meta¬analysis. Australian Crit. Care. 2011, vol. 24, no. 4, pp. 229¬243.
9. de Backer D., Aldecoa C., Njimi H. et al. Dopamine versus norepinephrine in the treatment septic shock: a meta¬analysis. Crit. Care Med. 2012, vol. 40, pp. 725¬730.
10. Delaney A.P., Dan A., McCaffrey J. et al. The role of albumin as a resuscitation fluid for patients with sepsis: A systematic review and meta¬analysis. Crit. Care Med. 2011, vol. 39, pp. 386¬391.
11. Dellinger R.P., Levy M.M., Carlet J. et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med. 2008, vol. 36, pp. 296¬327.
12. Dellinger R.P., Levy M.M., Rhodes A. et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit. Care Med. 2013, vol. 41, Suppl. 2, pp. 580¬637.
13. Guidet B., Martinet O., Boudain T. et al. Assessment hemodynamic efficacy and safety of 6% HES 130/0,4 vs 0,9% NaCl fluid replacement in patients with severe sepsis: The CRYSMAS study. Crit. Care. 2012, vol. 16, pp. R94.
14. Kumar A., Roberts D., Wood K.E. et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in septic shock. Crit. Care Med. 2006, vol. 34, pp. 1589¬1596.
15. Levy M., Dellinger R.P., Townsend S.R. et al. Surviving Sepsis Campaign: Results of international guideline¬based performance improvement program targeting severe sepsis. Crit. Care Med. 2010, vol. 38, pp. 367¬374.
16. McInture L., Fergusson D., Cook D. et al. Fluid resuscitation in management of early septic shock (FINESS): a randomized controlled feasibility trial. Can. J. Anaesth. 2008, vol. 55, pp. 819¬826.
17. Moor C.L., Osaki¬Kiyan P., Haque N. et al. Daptomycin vs Vancomycin for bloodstream infections due to methicillin¬resistant staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case¬control study. CID. 2012, vol. 54, pp. 51¬59.
18. Nguen H., Corbell S., Stede P. et al. Implementation of a bundle of indicators for early management severe sepsis and septic shock is associated with decreased mortality. Crit. Care Med. 2007, vol. 35, pp. 1100¬1112.
19. Prkno A., Wacker C., Brunkhorst F. et al. Procalcitonin¬guided therapy in ICU patients with severe sepsis and septic shock – a systematic review and meta-analysis. Crit. Care. 2013, vol. 17, pp. R291.
20. Shozushima T., Takahashi G., Matsumoto N. et al. Usefulness of presepsin measurement as marker for diagnosis and severity of sepsis that satisfied diagnostic criteria of SIRS. J. Infect. Chemother. 2011, vol. 17, no. 6, pp. 764¬769.
21. Ulla M., Pizzolato E., Lucchiari M. et al. Diagnostic and prognostic value of presepsin in the management of sepsis in emergency department: a multicenter prospective study. Crit. Care. 2013, – 17R:168.
22. Wacker C., Prkno A., Brunkhorst F., et al. Procalcitonin as diagnostic marker for sepsis:a systematic review and meta¬analysis. Lancet. 2013, vol. 13, no. 5, pp. 426¬435.
23. Yakovlev S., Beloborodov V., Suvorova M. et al. Multicentre study of the prevalence and clinical value of hospital¬acquired infections in emergency hospitals of Russia. Abstract K¬574. 54th ICAAC, Sept. 5¬9, 2014, USA, Washington, DC.
Review
For citations:
Kulabukhov V.V., Rudnov V.A. ANALYSIS OF COMPLIANCE WITH THE NEW STRATEGY FOR MANAGING SEPSIS PATIENTS AND INFECTION PREVENTION DURING INTENSIVE THERAPY. RESULTS OF MULTICENTER STUDY. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2015;12(2):7-13. (In Russ.) https://doi.org/10.21292/2078-5658-2015-12-2-7-13
Email this article 